German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patent
A German court on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna .
U.S. FDA places clinical hold on BioNTech's malaria vaccine study
BioNTech said in a regulatory filing on Tuesday the U.S. Food and Drug Administration has placed a clinical hold on an ...
Health Rounds: Roche/BioNTech experimental vaccine shows early promise in pancreatic cancer
Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following ...
Fierce Pharma3h
Pfizer, BioNTech notch US win—and loss in Germany—amid high-stakes patent fight with Moderna
As part of a global web of patent litigation over COVID-19 vaccines and mRNA technology, Pfizer and its partner BioNTech ...
Moderna: Patent Litigation Win Masks Underperformance, Unlikely To Pay Out
Moderna's legal win boosts stock but highlights mRNA technology struggles. Discover why MRNA stock may not sustain long-term ...
The Pharma Letter5h
FDA places clinical hold on BioNTech malaria trial
German biotech major BioNTech (Nasdaq: BNTX) has suffered a blow as it seeks to add new revenue streams beyond its COVID-19 ...
GlobalData on MSN1d
FDA puts clinical hold on BioNTech’s malaria vaccine trial
The FDA has ordered BioNTech to immediately halt its Phase I/II trial of malaria vaccine candidate BNT165e, pending changes.
FDA Places Clinical Hold On BioNTech's Early-Phase Trial For RNA-Based Malaria Vaccine
BioNTech's malaria vaccine trial faces an FDA clinical hold. The company is addressing concerns and collaborating with ...
Pfizer and BioNTech COVID vaccine broke patent: German court
A German court found Wednesday that American pharmaceutical giant Pfizer and German firm BioNTech violated a patent to make ...
Moderna Scores Legal Victory Over Pfizer, BioNTech in Patent Dispute
MODERNA (MRNA, Financial) secured a major legal win in its COVID-19 vaccine patent dispute with Pfizer (PFE, Financial) and ...
BioNTech (BNTX) Expected to Announce Quarterly Earnings on Monday
BioNTech (NASDAQ:BNTX – Get Free Report) will likely be issuing its quarterly earnings data before the market opens on Monday, March 10th. Analysts expect the company to announce earnings of $0.38 per ...
Pfizer and BioNTech violated COVID-19 vaccine patent held by Moderna, German court rules
The court said Pfizer and BioNTech would have to provide information on earnings derived from the use of the patent and that ...